共 21 条
[1]
Abe O, 1998, LANCET, V352, P930
[2]
ALBAIN K, 2004, IN PRESS BREAST CANC
[3]
ALBAIN KS, 2002, P ASCO, V21, P143
[5]
Bonetti M, 2000, STAT MED, V19, P2595, DOI 10.1002/1097-0258(20001015)19:19<2595::AID-SIM562>3.0.CO
[6]
2-M
[7]
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2003, 21 (08)
:1431-1439
[10]
POSTOPERATIVE CHEMOTHERAPY AND TAMOXIFEN COMPARED WITH TAMOXIFEN ALONE IN THE TREATMENT OF POSITIVE-NODE BREAST-CANCER PATIENTS AGED 50 YEARS AND OLDER WITH TUMORS RESPONSIVE TO TAMOXIFEN - RESULTS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT-B-16
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1990, 8 (06)
:1005-1018